Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-23

FDA Approved: ENTECAVIR — Original Application (Epic Pharma, LLC)

View source ↗

Summary

FDA approved Epic Pharma, LLC's original application for entecavir, a generic version of Baraclude, for the treatment of chronic hepatitis B infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENTECAVIR (ENTECAVIR)
  • ENTECAVIR ANHYDROUS (ENTECAVIR ANHYDROUS)

Snippet

ORIG AP for ENTECAVIR (ENTECAVIR)